Pharmacoeconomics

Health economics has been a long-standing focus of attention at Pierrel Research. We closely cooperate with health care providers, pharmaceutical or medical device companies, and third-party payers, including health insurance funds and governmental institutions, to develop and introduce new concepts of health care. Previous health economic projects include:

• Commercial opportunity assessment and estimation of market potential, related to the therapeutic areas in R&D, and marketing & sales, as well as to specific projects

• Development of health economic documentation for procedures and products in the development, pre-marketing and marketing phase of their life cycle

• Support of pricing decisions by identifying acceptable price ranges for new products

• Economic comparison of alternative treatment modalities

• Economic evaluation of disease and case management concepts

• De novo generation of health economic data.

These tasks were approached by means of e.g.:

• Strategic assistance

  Clinical trial, piggy-back study, randomised post-marketing surveillance, cost-effectiveness analysis, cost-benefit analysis, cost-utility analysis, cost-minimisation analysis, quality-of-life analysis and cross-design

• Planning

  Choice of study design, retrospective or prospective study

• Method

  Meta-analysis, clinical data modelling: Markov-type model and decision-analysis, incremental analysis, sensitivity analysis, discounting

• Execution

  According to relevant guidelines, study report, quality assurance, interpretation and valuation